Correlation Between Aura Biosciences and Lyra Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aura Biosciences and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aura Biosciences and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aura Biosciences and Lyra Therapeutics, you can compare the effects of market volatilities on Aura Biosciences and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aura Biosciences with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aura Biosciences and Lyra Therapeutics.

Diversification Opportunities for Aura Biosciences and Lyra Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Aura and Lyra is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Aura Biosciences and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Aura Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aura Biosciences are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Aura Biosciences i.e., Aura Biosciences and Lyra Therapeutics go up and down completely randomly.

Pair Corralation between Aura Biosciences and Lyra Therapeutics

Given the investment horizon of 90 days Aura Biosciences is expected to generate 0.59 times more return on investment than Lyra Therapeutics. However, Aura Biosciences is 1.7 times less risky than Lyra Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  999.00  in Aura Biosciences on November 19, 2024 and sell it today you would lose (204.00) from holding Aura Biosciences or give up 20.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aura Biosciences  vs.  Lyra Therapeutics

 Performance 
       Timeline  
Aura Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aura Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Lyra Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lyra Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Lyra Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Aura Biosciences and Lyra Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aura Biosciences and Lyra Therapeutics

The main advantage of trading using opposite Aura Biosciences and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aura Biosciences position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.
The idea behind Aura Biosciences and Lyra Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum